AZD3427 / AstraZeneca 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
2 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
AZD3427 / AstraZeneca
Re-PHIRE, NCT05737940: A Study of AZD3427 in Participants With Heart Failure and Pulmonary Hypertension Group 2

Recruiting
2
220
Europe, Canada, Japan, US, RoW
AZD3427, Placebo
AstraZeneca, Parexel
Pulmonary Hypertension (World Health Organization Group 2), Heart Failure
04/25
08/25
Re-PERFUSE, NCT06611423: AZD3427 Effects on Renal Perfusion in Heart Failure Patients With Reduced Ejection Fraction and Renal Impairment

Recruiting
1
12
Europe
AZD3427, AZD3427 Placebo, Dopamine, Radiolabelled ligand, Saline
AstraZeneca, CTC Clinical Trial Consultants AB, Karolinska Institutet
Heart Failure With Reduced Ejection Fraction (HFrEF), Renal Impairment
09/25
09/25

Download Options